Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
about
Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situEffect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?Web based pathology assessment in RTOG 98-04.The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast.The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative BiopsyDuctal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 YearsMolecular classification of non-invasive breast lesions for personalised therapy and chemopreventionTailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotypeHow Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local RecurrenceDuctal carcinoma in situ: an overview.The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast.Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.Controversies in the Treatment of Ductal Carcinoma in Situ.Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.
P2860
Q26864448-9D7ADF93-C096-487D-A129-5B879B64AC21Q33617264-0E0E6D88-A9D5-42CA-8379-AD27AF3B6C9CQ34043363-A593059D-CD25-476B-BF8A-52530A46A346Q34092275-B0C81D0F-121A-4A4C-8B50-0CE0D4112E67Q35660389-7A631E31-8108-4456-8EA0-3A7C44D3BCF2Q36004719-7E3876B0-AE0C-4702-A962-E2F64397A3CCQ36113082-B631132B-F6E3-4D18-ABA0-5EDE5E692BD6Q36277567-EE56A606-337B-4C94-9CB1-6BBCE907DFB5Q36395910-4DACDB3F-2F36-4E6B-A7B0-0C3F75931993Q36539386-226E5AD2-0AF1-428E-8C0A-32F844A7D4A0Q36685380-3B7895C1-00BA-4324-81FE-17F977E0825AQ36889682-A0D9B53B-2468-485A-A15A-61C00AD4CC9FQ36902060-E157C271-0066-4B6E-BDF6-CDAB708B8E33Q37040692-39F5B53A-F60B-41EA-88EA-7BBCEAA34DAEQ37292550-0D1B9675-F05A-4240-8F0E-6074E5F34D09Q38132242-DD58D236-FC47-4F59-96C6-0F14AA72C9B0Q39201898-6972DBFB-B107-42CC-BDF6-79FBAA8ECA07Q40075698-514EB319-52C2-453C-9DDA-9C190D20AE36Q40745228-FF304BF7-7E48-4188-A92F-FF0BB4202A9CQ45393620-FB35D399-FCB1-49D9-93B4-B62C33D06F5CQ45890164-CCB4DA48-169A-457F-B4DA-D1139236C20BQ46057336-A09EB7C2-2712-4F03-A10C-16B4029C2B27Q46124060-2597F0B5-B265-44A9-AE20-AAC502D6E278Q46699535-13CC4778-D02B-4D03-AE07-5F78AAB5A0ADQ47304201-F0C2E47D-9D80-4F02-83D6-EEBD41DF89F0Q48273329-4140D6A8-6A11-4EA1-8ADA-55D105E750A2Q49657306-1F3DD213-7F7B-4E96-8763-6F0D3A8A28A9Q54446665-0617CE06-55C6-4902-9979-D2470D27CBC5
P2860
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of a breast cancer ...... in situ after local excision.
@ast
Evaluation of a breast cancer ...... in situ after local excision.
@en
type
label
Evaluation of a breast cancer ...... in situ after local excision.
@ast
Evaluation of a breast cancer ...... in situ after local excision.
@en
prefLabel
Evaluation of a breast cancer ...... in situ after local excision.
@ast
Evaluation of a breast cancer ...... in situ after local excision.
@en
P2093
P2860
P356
P1476
Evaluation of a breast cancer ...... in situ after local excision.
@en
P2093
Anthony Lucci
Elizabeth A Mittendorf
Henry M Kuerer
Isabelle Bedrosian
Jaime R Crow
Kelly K Hunt
Rosa F Hwang
P2860
P304
P356
10.1200/JCO.2011.36.4976
P407
P577
2012-01-17T00:00:00Z